Two new studies at the @EANeurology found that non-medical use of both prescription stimulants and nitrous oxide (laughing gas) has been increasing amongst young people. Read more: https://t.co/akdbLbNcez
A novel synthetic opiate, #isotonitazene, has been linked to opioid deaths in three states. Coroners plan on adding the drug to toxicity screens to gain a broader understanding of its role in overdoses across the country. Read more: https://t.co/zTkpGTJ2V9
The #COVID-19 pandemic has created additional barriers in access to care for people with substance use disorders, increasing the need for harm reduction efforts and conversations on how to address intersecting health crises. Learn more: https://t.co/ytFpuaV9Ry
A new study has shown that ADHD medications, such as Ritalin and Adderall, alter cognitive function by increasing cognitive motivation, so perceived benefits of performing a task are elevated, and the perceived costs are reduced. Read more: https://t.co/xROYyceVd9
A study from @JohnsHopkins found that buprenorphine treatment among people with HIV may lead to a decrease in HIV RNA viral loads, resulting in a lower overall risk of transmission. https://t.co/XuD2UmOSsn
Research into Huwentoxin-IV, a peptide found in the venom of Chinese bird spiders, may potentially lead to an alternative method of treating pain, without the side effects of opioids. Learn more: https://t.co/YtDWnYPdj2
Will the COVID-19 outbreak lead to an increase in opioid use? Researchers and policymakers express concern that social isolation and lack of resources for people in recovery may spur on the opioid epidemic. Read more: https://t.co/PFw4WlH0yq
Kratom has been increasingly used as an alternative to opioid drugs. Recently, the Drug-Induced Liver Injury Network has been raising concerns about potential liver disease associated with kratom use. Learn more: https://t.co/aWM5JcrzoK
A recent paper published in @ijdrugpolicy investigated intentional fentanyl use among harm reduction site clients in British Columbia, Canada. Read the whole abstract here: https://t.co/MUqf4ef2Sp
The most common product recorded on the site in covered European countries (DE, ES, FR, UK) was #methylphenidate, comprising 24% of total European submissions in December. https://t.co/BmiACZpbkb
@MAPS recently received the green light from the FDA to offer MDMA therapy, outside of clinical trials, to service members and veterans with PTSD. Learn more: https://t.co/s9MHe864fc
@NIDANews is investing in an artificial intelligence-based tool to track illegal online sales of controlled substances. Learn more about this initiative:
https://t.co/PDwXc0olhp
A study published in @JAMANetworkOpen found that the Medicaid expansion was linked to a 6 percent decline in opioid overdose death rates, contradicting claims that this expansion would worsen the crisis due to increased access to opioids. Learn more: https://t.co/bEaP1GjB1y
A recent study published in @PNASNews found that significant use of coffee, nicotine, or amphetamines during pregnancy resulted in a higher risk of children having neurological and psychiatric problems. Read a summary: https://t.co/D8Nwjyf4FM.